FR2451913B1 - - Google Patents

Info

Publication number
FR2451913B1
FR2451913B1 FR8006390A FR8006390A FR2451913B1 FR 2451913 B1 FR2451913 B1 FR 2451913B1 FR 8006390 A FR8006390 A FR 8006390A FR 8006390 A FR8006390 A FR 8006390A FR 2451913 B1 FR2451913 B1 FR 2451913B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8006390A
Other languages
French (fr)
Other versions
FR2451913A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Continental Pharma Inc
Original Assignee
Continental Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU81069A external-priority patent/LU81069A1/fr
Priority claimed from LU81068A external-priority patent/LU81068A1/fr
Application filed by Continental Pharma Inc filed Critical Continental Pharma Inc
Publication of FR2451913A1 publication Critical patent/FR2451913A1/fr
Application granted granted Critical
Publication of FR2451913B1 publication Critical patent/FR2451913B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8006390A 1979-03-22 1980-03-21 Derives de la glycinamide, leur preparation et leur utilisation dans le traitement de diverses formes d'epilepsie, des dyskinesies et des troubles de la memoire Granted FR2451913A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU81069A LU81069A1 (fr) 1979-03-22 1979-03-22 Derive de glycinamide, preparation de ce derive, son utilisation ainsi que composition contenant ce derive
LU81068A LU81068A1 (fr) 1979-03-22 1979-03-22 Derives de la glycinamide, leur preparation et utilisation, ainsi que compositions contenant ces derives

Publications (2)

Publication Number Publication Date
FR2451913A1 FR2451913A1 (fr) 1980-10-17
FR2451913B1 true FR2451913B1 (enExample) 1984-07-13

Family

ID=26640253

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8006390A Granted FR2451913A1 (fr) 1979-03-22 1980-03-21 Derives de la glycinamide, leur preparation et leur utilisation dans le traitement de diverses formes d'epilepsie, des dyskinesies et des troubles de la memoire

Country Status (18)

Country Link
US (1) US4639468A (enExample)
AT (1) AT381302B (enExample)
AU (1) AU536499B2 (enExample)
CA (1) CA1184567A (enExample)
CH (1) CH645091A5 (enExample)
DE (2) DE3010599A1 (enExample)
DK (1) DK162714C (enExample)
ES (1) ES490536A0 (enExample)
FI (1) FI82033C (enExample)
FR (1) FR2451913A1 (enExample)
GB (1) GB2048852B (enExample)
GR (1) GR68005B (enExample)
IE (1) IE49751B1 (enExample)
IL (1) IL59679A (enExample)
NL (1) NL191508C (enExample)
NO (1) NO157817C (enExample)
PT (1) PT70992A (enExample)
SE (1) SE453917B (enExample)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2937698A1 (de) * 1979-09-18 1981-04-02 A. Nattermann & Cie GmbH, 5000 Köln N-propionylsarcosinanilide, deren herstellungsverfahren und arzneimittel auf deren basis
DK373383A (da) * 1982-08-20 1984-02-21 Midit Fremgangsmaade til fremstilling af omega-aminosyrederivater
US4798687A (en) * 1987-02-06 1989-01-17 Pennwalt Corporation 2-Amino-N-[1,2-Diphenyl-1-(thifluoromethyl)ethyl]acetamide derivatives
US4904681A (en) * 1987-12-01 1990-02-27 G. D. Searle & Co. D-cycloserine and its prodrugs as cognitive enhancers
US4891058A (en) * 1988-07-18 1990-01-02 Ici Americas Inc. 1-alkyl-3-aryl imidazolidine-2,4-diones and herbicidal use
US5278191A (en) * 1988-08-31 1994-01-11 G. D. Searle & Co. Diphenylmethylaminoacetamide derivatives as anti-convulsants
US5288905A (en) * 1988-10-07 1994-02-22 G. D. Searle & Co. Glycyl urea derivatives as anti-convulsants
US4944796A (en) * 1988-11-14 1990-07-31 Ici Americas Inc. Certain 2-(disubstituted amino) acetanilide herbicides
DE3915755A1 (de) * 1989-05-13 1990-11-29 Bayer Ag Fungizide mittel sowie substituierte aminosaeureamid-derivate und deren herstellung
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
US5075337A (en) * 1989-07-26 1991-12-24 G. D. Searle & Co. Alpha-deuterated 2-alkylaminoacetamide derivatives having reduced toxicity for treatment of CNS disorders
US5153226A (en) * 1989-08-31 1992-10-06 Warner-Lambert Company Acat inhibitors for treating hypocholesterolemia
DE4102042A1 (de) * 1991-01-24 1992-07-30 Bayer Ag Substituierte aminosaeureamid-derivate deren herstellung und verwendung als fungizide
US5141960A (en) * 1991-06-25 1992-08-25 G. D. Searle & Co. Tricyclic glycinamide derivatives as anti-convulsants
GB9306886D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
GB9306899D0 (en) * 1993-04-01 1993-05-26 Erba Carlo Spa Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
US5585358A (en) * 1993-07-06 1996-12-17 Yissum Research Development Corporation Of The Hebrew University Of Jerusalem Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents
US6191165B1 (en) * 1996-05-31 2001-02-20 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
CA2619901A1 (en) * 1996-05-31 1997-12-04 Allelix Neuroscience Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
IT1283489B1 (it) * 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
US6984754B1 (en) 1998-03-26 2006-01-10 University Of Saskatchewan Technologies Inc. Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents
TR200002756T2 (tr) * 1998-03-26 2000-12-21 University Of Saskatchewan Technologies Inc. Hücresel kurtarma maddeleri olarak alifatik amino karboksilik ve amino fosfonik asitler, amino nitriller ve amino tetrazoller.
AU2985100A (en) * 1999-02-08 2000-08-25 Checkpoint Genetics, Inc. (n)-substituted amino acids, antioxidant pharmaceutical compositions containing same and methods using same
PL365588A1 (en) * 2000-07-21 2005-01-10 Teva Pharmaceutical Industries, Ltd. Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
SI1311256T1 (sl) * 2000-08-17 2005-12-31 Teva Pharma Uporaba derivatov amidov valprojske kisline in amidov 2-valproenske kisline za zdravljenje ali preprecevanje bolecin in/ali glavobolnih motenj
WO2002042256A2 (en) * 2000-11-21 2002-05-30 Ucb, S.A. N-alkylated gaba compounds, processes for their preparation and their use as medicaments
AU2002235682C1 (en) 2001-02-16 2008-12-11 Nps Pharmaceuticals, Inc. Thiophene substituted amine derivatives as GLYT-1 inhibitors
US20030035784A1 (en) * 2001-03-05 2003-02-20 Kao Corporation Hair cosmetic, aminocarboxylic acid amide and method for producing the same
ATE317280T1 (de) 2001-09-03 2006-02-15 Newron Pharm Spa Pharmazeutische zusammensetzung mit gabapentin oder deren analog und einem alpha-aminoamid und analgetische verwendung dieser zusammensetzung
EP1438956A1 (en) * 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as antimigraine agents
SI1809271T1 (sl) * 2004-09-10 2010-10-29 Newron Pharm Spa Uporaba (R)-(halobenziloksi) benzilamino propanamidov kot selektivnih modulatorjev natrijevih in/ali kalcijevih kanalov
BRPI0515260A (pt) * 2004-09-13 2008-07-15 Ciba Sc Holding Ag aditivos lubrificantes de alquilaminoacetamida
FR2896991A1 (fr) * 2006-02-03 2007-08-10 Inst Nat Sante Rech Med Procede pour preparer un compose organique a l'etat solide et compositions pharmaceutiques comprenant ledit compose organique
CN102351733B (zh) * 2011-07-21 2014-03-19 凯莱英医药化学（阜新）技术有限公司 一种制备2-氨基-n,n-二甲基乙酰胺盐酸盐的方法
WO2015199952A1 (en) 2014-06-25 2015-12-30 Acuitas Therapeutics Inc. Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
JP6053724B2 (ja) * 2014-06-26 2016-12-27 国立大学法人九州大学 イオン交換樹脂及び金属の吸着分離方法
HUE067372T2 (hu) 2015-06-29 2024-10-28 Acuitas Therapeutics Inc Lipidek és nanoszemcsés lipid formulázások nukleinsavak beadására
IL286515B2 (en) 2015-10-28 2024-02-01 Acuitas Therapeutics Inc Novel lipids and nanoparticle formulations of lipids for delivery of nucleic acids
CN106187829B (zh) * 2016-07-29 2017-12-15 万华化学集团股份有限公司 一种制备乙二胺基乙磺酸盐的方法
WO2018191657A1 (en) 2017-04-13 2018-10-18 Acuitas Therapeutics, Inc. Lipids for delivery of active agents
ES2981244T3 (es) 2017-04-28 2024-10-07 Acuitas Therapeutics Inc Novedosas formulaciones de nanopartículas de lípidos de carbonilo y lípidos para la administración de ácidos nucleicos
US11639329B2 (en) 2017-08-16 2023-05-02 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
WO2019036000A1 (en) * 2017-08-17 2019-02-21 Acuitas Therapeutics, Inc. LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS
US11542225B2 (en) 2017-08-17 2023-01-03 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
US11524932B2 (en) 2017-08-17 2022-12-13 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
US12329857B2 (en) 2018-09-21 2025-06-17 Acuitas Therapeutics, Inc. Systems and methods for manufacturing lipid nanoparticles and liposomes
KR101953366B1 (ko) 2018-12-26 2019-02-28 정종문 침향을 포함하는 기억력 및 인지능력을 향상시키는 기능성 건강식품 및 이의 제조방법
JP7523449B2 (ja) 2019-01-11 2024-07-26 アクイタス セラピューティクス インコーポレイテッド 活性剤の脂質ナノ粒子送達のための脂質
USD926577S1 (en) 2019-09-23 2021-08-03 Verdant Ventures Tamper-resistant lid assembly
US11326923B2 (en) 2019-10-08 2022-05-10 Verdant Ventures Tamper-resistant lid assembly for dispensing a premeasured amount of liquid
CN116096702A (zh) 2020-07-16 2023-05-09 爱康泰生治疗公司 用于脂质纳米颗粒的阳离子脂质
EP4448485A2 (en) 2021-12-16 2024-10-23 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2368208A (en) * 1940-12-16 1945-01-30 Emulsol Corp Chemical compounds and method of preparing same
US2781385A (en) * 1953-09-21 1957-02-12 Gefgy Chemical Corp Diamidocarboxylic acids and certain salts thereof
FI41563B (enExample) * 1962-05-09 1969-09-01 Ferrosan Ab
JPS5319654B2 (enExample) 1974-03-14 1978-06-22
DE2832009A1 (de) 1978-07-20 1980-01-31 Deutsches Krebsforsch Verwendung von sarkosin und sarkosinderivaten ls tumorhemmende wirksubstanzen

Also Published As

Publication number Publication date
US4639468A (en) 1987-01-27
CH645091A5 (fr) 1984-09-14
ES8104790A1 (es) 1981-04-16
FR2451913A1 (fr) 1980-10-17
CA1184567A (en) 1985-03-26
NL191508B (nl) 1995-04-18
IL59679A0 (en) 1980-06-30
AT381302B (de) 1986-09-25
DK162714C (da) 1992-04-21
SE453917B (sv) 1988-03-14
NO800830L (no) 1980-09-23
DE3010599A1 (de) 1980-10-09
NO157817B (no) 1988-02-15
NO157817C (no) 1988-05-25
GB2048852B (en) 1983-03-30
NL8001721A (nl) 1980-09-24
DE3010599C2 (enExample) 1989-03-02
DK162714B (da) 1991-12-02
SE8002204L (sv) 1980-09-23
FI800900A7 (fi) 1980-09-23
DE3050800C2 (enExample) 1989-06-22
FI82033C (fi) 1991-01-10
ATA154680A (de) 1986-02-15
FI82033B (fi) 1990-09-28
AU536499B2 (en) 1984-05-10
IE800599L (en) 1980-09-22
IL59679A (en) 1984-11-30
NL191508C (nl) 1995-08-21
GR68005B (enExample) 1981-10-26
DK123580A (da) 1980-09-23
ES490536A0 (es) 1981-04-16
GB2048852A (en) 1980-12-17
PT70992A (fr) 1980-04-01
AU5678480A (en) 1980-09-25
IE49751B1 (en) 1985-12-11

Similar Documents

Publication Publication Date Title
GR68005B (enExample)
FR2448970B3 (enExample)
BR8002583A (enExample)
BR8006808A (enExample)
AT364253B (enExample)
FR2449165B1 (enExample)
BR5901094U (enExample)
AU77763S (enExample)
AU78270S (enExample)
AU78271S (enExample)
AU78385S (enExample)
AU78386S (enExample)
AU78389S (enExample)
AU78390S (enExample)
AU78391S (enExample)
AU78569S (enExample)
AU79200S (enExample)
AU79557S (enExample)
AU79558S (enExample)
AU79559S (enExample)
AU79826S (enExample)
AU79918S (enExample)
AU79950S (enExample)
AU80228S (enExample)
AU77669S (enExample)

Legal Events

Date Code Title Description
TP Transmission of property